2020-12-14 12:01:01 · Revision 1
Class 4 Medicines Defect Information: Generics [UK] Limited t/a Mylan, EL(20)A/58
Generics [UK] Limited t/a Mylan have informed us that the Patient Information Leaflet (PIL) within the packs for the products listed above is missing relevant important safety information.
Read full MHRA notice ↗Source: Medicines and Healthcare products Regulatory Agency (MHRA). Read the full notice, including its required actions and deadlines, before recording your response.